Identification of Distinct Subtypes in Immune Tolerance after Hematopoietic Cell Transplantation Using the Prospective ABLE1.0 Pediatric Study Cohort.

Saved in:
Bibliographic Details
Title: Identification of Distinct Subtypes in Immune Tolerance after Hematopoietic Cell Transplantation Using the Prospective ABLE1.0 Pediatric Study Cohort.
Authors: Ng B; Department of Statistics, Centre for Molecular Medicine and Therapeutics, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada., Harris AC; MSK Kids Stem Cell Transplantation and Cellular Therapies, Memorial Sloan Kettering Cancer Center, New York, New York., Abdossamadi S; Michael Cuccione Childhood Cancer Research Program, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada., Lauener MP; Michael Cuccione Childhood Cancer Research Program, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada., Aubert G; Repeat Diagnostics Inc, North Vancouver, British Columbia, Canada., Bajwa R; Nationwide Children's Hospital Columbus, Ohio., Bhatia M; Pediatric Stem Cell Transplant Program, Morgan Stanley Children's Hospital, Columbia University, New York, New York., Bittencourt H; Pediatric Hematology-Oncology Division, Saint-Justine University Hospital Centre, Montreal, Quebec, Canada., Buxbaum NP; Roswell Park Comprehensive CancerCancer Center, Buffalo, New York., Caywood EH; Nemours Children's Health, Thomas Jefferson University, Wilmington, Delaware; Thomas Jefferson University, Philadelphia, Pennsylvania., Chaudhury S; Hematology, Oncology, Neuro-Oncology & Stem Cell Transplantation, Ann & Robert H. Lurie Children's Hospital, Northwestern University, Chicago, Illinois., Chewning JH; Division of Pediatric Hematology and Oncology, University of Alabama at Birmingham, Birmingham, Alabama., Choi SW; University of Michigan, Blood and Marrow Transplantation Program, Ann Arbor, Michigan., Chopek A; Manitoba Blood and Marrow Transplant Program, CancerCare Manitoba, University of Manitoba, Winnipeg, Manitoba, Canada., Chu J; Pediatric Blood and Marrow Transplant Program, Benioff Children's Hospital, University of California San Francisco, San Francisco, California., Coulter D; Division of Pediatric Hematology-Oncology, University of Nebraska Medical Center, Omaha, Nebraska., Gadalla SM; Clinical Genetics Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Hogg RT; Michael Cuccione Childhood Cancer Research Program, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada., Jacobsohn DA; Division of Blood and Marrow Transplantation, Children's National Hospital, George Washington University School of Medicine and Health Sciences, Washington, District of Columbia., Johnson AK; Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant. University of Utah/Primary Children's Hospital, Salt Lake City, Utah., Joyce M; Nemours Children's Health, Jacksonville, Florida., Kasow KA; Pediatric Bone Marrow Transplant, University of North Carolina, Chapel Hill, North Carolina., Kent M; Atrium Health/Levine Children's Charlotte, North Carolina., Kitko CL; Pediatric Stem Cell Transplant Program, Vanderbilt University Medical Center, Nashville, Tennessee., Lau D; Michael Cuccione Childhood Cancer Research Program, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada., Lawitschka A; Stem Cell Transplant Unit, St. Anna Children's Hospital, Medical University, Vienna, Austria., Lewis VA; Pediatric Oncology and Transplant, Alberta Children's Hospital, University of Calgary, Calgary, Alberta, Canada., Li AM; Michael Cuccione Childhood Cancer Research Program, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada., McLaughlin L; Children's Hospital Colorado Denver, Colorado., Mitchell D; Division of Pediatric Hematology-Oncology, Montreal Children's Hospital, McGill University, Montreal, Quebec, Canada., Nemecek ER; Pediatric Blood and Marrow Transplantation, Doernbecher Children's Hospital, Oregon Health and Sciences University, Portland, Oregon., Parthasarathy V; Michael Cuccione Childhood Cancer Research Program, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada; Allen Institute for Immunology, Seattle, Washington., Pawlowska AB; Pediatric Hematology, Oncology and Hematopoietic Stem Cell Transplant. City of Hope, Duarte, California., Pirsl F; Division of Blood and Marrow Transplantation, Children's National Hospital, George Washington University School of Medicine and Health Sciences, Washington, District of Columbia., Pulsipher MA; Division of Pediatric Hematology, Oncology, and Bone Marrow Transplant. University of Utah/Primary Children's Hospital, Salt Lake City, Utah., Qayed M; Emory University School of Medicine, Atlanta, Georgia., Rozmus J; Michael Cuccione Childhood Cancer Research Program, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada., Savaşan S; Pediatric Hematology & Oncology, Children's Hospital of Michigan, Detroit, Michigan., Schechter T; Pediatric Hematology-Oncology, Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada., Shenoy S; Washington University School of Medicine, St. Louis, Missouri., Suleimenova A; Michael Cuccione Childhood Cancer Research Program, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada., Zheng DJ; Michael Cuccione Childhood Cancer Research Program, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada., Ostroumov E; Michael Cuccione Childhood Cancer Research Program, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada., Geltink RIK; Department of Pathology and Laboratory Medicine, University of British Columbia, British Columbia Children's Hospital, Vancouver, British Columbia, Canada., Gilman A; ICON Biotech, Center for Cell and Gene Therapy, Charlotte, North Carolina., Wolff D; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Cuvelier GDE; Pediatric Oncology and Transplant, Alberta Children's Hospital, University of Calgary, Calgary, Alberta, Canada., Schultz KR; Michael Cuccione Childhood Cancer Research Program, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: kschultz@mail.ubc.ca.
Source: Transplantation and cellular therapy [Transplant Cell Ther] 2026 Jan; Vol. 32 (1), pp. 84.e1-84.e16. Date of Electronic Publication: 2025 Sep 29.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-6367
DOI:10.1016/j.jtct.2025.09.034